Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial. [electronic resource]
Producer: 20191016Description: 65-73 p. digitalISSN:- 1097-6744
- Angina, Unstable -- epidemiology
- Benzaldehydes -- therapeutic use
- Coronary Disease -- complications
- Endpoint Determination
- Heart Failure -- epidemiology
- Hospitalization -- statistics & numerical data
- Humans
- Ischemic Attack, Transient -- epidemiology
- Kaplan-Meier Estimate
- Myocardial Infarction -- epidemiology
- Oximes -- therapeutic use
- Percutaneous Coronary Intervention -- statistics & numerical data
- Phospholipase A2 Inhibitors -- therapeutic use
- Placebos -- therapeutic use
- Stroke -- epidemiology
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.